Kopran (KOPRAN.NS) Stock Price

Kopran Price

NSE·CLOSED
276.50
​
Market closed

Over the last 19 years Kopran grew revenue by 7.6% annually, reaching 6.30 B INR. Earnings per share have grown at 3.2% per year over the last 17 years. For Kopran, the net margin of 6.1% is down versus 12.5% a few years ago. At today's price the dividend yield works out to roughly 1.08%. The payout ratio is around 38% of earnings. The dividend has grown at 14.9% per year over the past 5 years.

Kopran stock price

Access this data via the Eulerpool API

Kopran business model & stock analysis

Kopran Ltd. is a holding company, which engages in the manufacturing of pharmaceuticals and related products. The company is headquartered in Mumbai, Maharashtra and currently employs 394 full-time employees. The firm is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (APIs). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The firm's penicillin-based finished oral dosage forms include anti-infective, amoxycillin, ampicillin, cloxacillin and amoxy clauv. Its non-penicillin-based finished oral dosage forms include macrolides, anti-hypertensive, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management and gastroenterology. The company provides ingredients in a wide range of pharmaceutical products, such as capsules, injectables and tablets, among others. The firm's APIs products include anti-hypertensive, macrolides, neuromodulator, urological, anti-infective/anti-acne, sterile carbapenems and sterile cephalosporins.

Frequently asked questions about Kopran

5 analysts currently rate the Kopran stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Kopran to generate revenue of 4.15 B INR and earnings per share of 7.08 INR.

Converted at the current exchange rate, the Kopran share trades at 2.55 EUR (276.50 INR).

The Kopran share (KOPRAN.NS) is listed on 2 stock exchanges, including: NSE (Indien) (KOPRAN.NS).

The expected revenue of Kopran is 4.15 B INR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Kopran is 341.89 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Kopran is currently 39.05. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Kopran stock.

The price-to-sales ratio (P/S) of Kopran is currently 3.22. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Kopran stock.

The Eulerpool Quality Score for Kopran is 6/10.

The ISIN of Kopran is INE082A01010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Kopran is KOPRAN.NS. The ticker symbol is used to trade Kopran shares on the stock exchange.

Fair ValueTerminal
290.33 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
15.98 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website kopran.com
Country
Currency
INR
Initial public offering
Nov 17, 1992
ISIN
INE082A01010
Cusip
Y4821P114
Market capitalization
13.35 B INRLarge Cap
52-Week Range
PEG
29.87
P/E ratio
P/Ee 2026
39.05
P/Ee 2027
58.09
P/Ee 2028
46.01
P/Ee 2029
43.14
P/Ee 2030
36.87
P/S
P/Se
3.22
EV/EBIT
24.95
P/B Ratio
2.58
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.81 %
Dividend
Dividend yield
1.08 %
Est. Dividend Yield
1.08 %
Payout Ratio
37.57 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
3 years
Dividend not reduced since
3 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Oct 9, 2026, 4:37 AM

Kopran Peer Group

Kopran Ticker

BSE · KOPRAN.BONSE INDIA · KOPRAN.NS

Kopran FIGI

KOP:IN · BBG000CVBZT6KOP:IB · BBG000CVC0V9KOP:IS · BBG000CVD315KOP:IG · BBG003NVX0X6

All fundamentals and in-depth analysis of Kopran

Our stock analysis for Kopran stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kopran. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.